CBS
Dr. Sandra Kweder of the FDA said the NIH study is the first to show that naproxen might increase the risk of heart attack or stroke.

WASHINGTON (CBS) A study testing whether Celebrex or naproxen would reduce the risk of Alzheimer's disease was halted Monday after researchers noted an increase in heart attack and stroke among participants who were taking naproxen, an over-the-counter pain reliever on the market for nearly 30 years.


FULL STORY AT CBS


FOX NEWS: NIH Halts Celebrex, Naproxen Study

She said patients who routinely take naproxen should follow the drug directions carefully, including the instruction not to take it for more than 10 days, and to consult a doctor if there continues to be pain.